AICAR

Also known as: Acadesine, AICA Riboside, 5-Aminoimidazole-4-carboxamide ribonucleotide

Metabolic

Phase II

AICAR is an AMP-activated protein kinase (AMPK) activator that mimics the metabolic effects of exercise at a cellular level, improving endurance, fat oxidation, glucose uptake, and metabolic efficiency without physical activity.

Regulatory & Approval Status

Not FDA Approved

AICAR has been examined in phase 2 clinical trials for conditions like Type 2 Diabetes, but it remains a research-only compound without FDA approval.

Information compiled from FDA compounding guidance and public regulatory sources. For research and educational purposes only; not medical advice.

Unlock the complete research profile

Create your free CertifiedTide account to access full compound details, mechanisms, safety data, and research tools.